B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids. [electronic resource]
Producer: 20081204Description: 195-6 p. digitalISSN:- 1432-5233
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antirheumatic Agents -- therapeutic use
- B-Lymphocytes -- pathology
- Combined Modality Therapy
- Cyclosporine -- therapeutic use
- Diabetes Mellitus, Type 1 -- complications
- Drug Delivery Systems
- Female
- Humans
- Immunosuppression Therapy -- methods
- Immunosuppressive Agents -- therapeutic use
- Leukapheresis -- methods
- Lupus Erythematosus, Systemic -- complications
- Rituximab
- T-Lymphocytes -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.